Anzeige
Mehr »
Dienstag, 28.10.2025 - Börsentäglich über 12.000 News
Atomkraft feiert Comeback: Uran wird wieder zum strategischen Rohstoff - Anleger stehen Schlange
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A41HUM | ISIN: US09075X2071 | Ticker-Symbol:
NASDAQ
27.10.25 | 19:46
6,700 US-Dollar
0,00 % 0,000
Branche
Biotechnologie
Aktienmarkt
Sonstige
1-Jahres-Chart
BIODESIX INC Chart 1 Jahr
5-Tage-Chart
BIODESIX INC 5-Tage-Chart

Aktuelle News zur BIODESIX Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
MiBiodesix stock rises after expanded Bio-Rad partnership1
MiBiodesix to validate ESR1 mutation test for advanced breast cancer1
MiBiodesix validiert ESR1-Mutationstest für fortgeschrittenen Brustkrebs1
MiBiodesix, Inc.: Biodesix Announces Expanded Bio-Rad Laboratories Partnership Agreement to Develop Droplet Digital PCR High Complexity Assays223LOUISVILLE, Colo., Oct. 22, 2025 (GLOBE NEWSWIRE) -- Biodesix, Inc. (NYSE: BDSX), a leading diagnostics solutions company, today announced the signing of an expanded partnership agreement under which...
► Artikel lesen
15.10.Biodesix, Inc.: Biodesix Announces Presentations and Events at the CHEST 2025 Annual Meeting1
06.10.Biodesix, Inc.: Biodesix Unveils October Lung Health Events in Colorado with the Association of Pulmonary Advanced Practice Providers (APAPP), American Lung Association in Colorado, and GO2 for Lung Cancer Centers of Excellence Summit1
01.10.BIODESIX INC - 8-K, Current Report1
BIODESIX Aktie jetzt für 0€ handeln
19.09.Canaccord senkt Kursziel für Biodesix auf 20 US-Dollar, bestätigt aber Kaufempfehlung2
19.09.Biodesix stock price target lowered to $20 by Canaccord, maintains Buy rating1
11.09.Biodesix, Inc.: Biodesix Announces One-for-Twenty Reverse Stock Split114LOUISVILLE, Colo., Sept. 11, 2025 (GLOBE NEWSWIRE) -- Biodesix, Inc. (Nasdaq: BDSX) ("Biodesix" or the "Company"), a leader in personalized diagnostics, today announced a one-for-twenty reverse stock...
► Artikel lesen
11.09.BIODESIX INC - 8-K, Current Report3
04.09.Biodesix Stock Surges Over 51% Overnight After Jack Schuler's $1.5M Share Purchase Revealed2
19.08.Biodesix, Inc.: Biodesix Recognized as a Thermo Fisher Scientific Center of Excellence (COE) for NGS Diagnostics5
07.08.Biodesix GAAP EPS of -$0.08 misses by $0.01, revenue of $20M beats by $1.53M2
07.08.BIODESIX INC - 10-Q, Quarterly Report2
07.08.Biodesix, Inc.: Biodesix Announces Second Quarter 2025 Results and Highlights178Q2 2025 Revenue of $20.0 million, an increase of 12% over Q2 2024; Q2 2025 gross profit margin of 80%, a 150-basis point improvement from Q2 2024; Reiterating FY2025 Total Revenue Guidance...
► Artikel lesen
07.08.BIODESIX INC - 8-K, Current Report2
24.07.Biodesix, Inc.: Biodesix to Report Second Quarter 2025 Financial Results on August 7, 20251
10.06.Biodesix, Inc.: Biodesix Partners with Association of Pulmonary Advanced Practice Providers (APAPP) to Deliver Nation's First Medical Education for APPs on Biomarkers in Lung Nodule and Lung Cancer Programs1
04.06.Biodesix auf der 45. jährlichen William Blair Growth Stock Konferenz: Fokus auf Lungengesundheit3
Weiter >>
37 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1